Poster # 2309 Analysis Of Potential Cost Benefits Using Reported Hypofractionated Radiation Therapy Regimens In Prostate Cancer In The United States

Presenter: Pawel Mroz, MD, PhD

About the Presenter:
Dr Pawel Mroz received his MD and PhD degrees from the Medical University of Warsaw, Poland. He joined the Wellman Center for Photomedicine at Massachusetts General Hospital, Harvard Medical School as a postdoctoral research fellow in the laboratory of Dr Michael R. Hamblin in 2005. In 2008 he was appointed as an Instructor at HMS and Assistant in Immunology at MGH and Wellman Center. Dr Mroz has been investigating the variety of anti-tumor immune responses after photodynamic therapy; in particular he has been investigating the role of T regulatory cells and tumor antigens in this process. Additionally, he has been involved in several projects evaluating the applications of new photosensitizers for PDT of cancer. This experience resulted in the acceptance of several peer-reviewed articles for publication in the scientific journals Nature Reviews Cancer, PNAS, Cancer Research, FRBM and FASEBJ. Dr Mroz has also contributed several book chapters and edited a book on PDT of cancer. Dr Mroz has also received several awards for his research. To complement his research endeavors, Dr Mroz completed the course “Design and Conduct of Clinical Trials” organized by MGH Clinical Research Program and followed this experience with subsequent visits to the Radiation Oncology Departments at the University of Pennsylvania Hospital, at Harvard Medical School and at Tufts Medical Center to deepened his clinical experience in the USA. Working with such great mentors like Dr Steve Hahn, Dr Anthony D'Amico and Dr Kathryn Huber and Dr David Wazer offered him unique insights into the responsibilities, challenges, joys and fulfillment of a Radiation Oncologist.

Abstract:


E-mail a friend about this poster:
Enter email address: